428 related articles for article (PubMed ID: 18644910)
1. When a Parkinson's disease patient starts to hallucinate.
Poewe W
Pract Neurol; 2008 Aug; 8(4):238-41. PubMed ID: 18644910
[TBL] [Abstract][Full Text] [Related]
2. [Hallucinations in Parkinson's disease].
Moser A; Hagenah J; Kömpf D
Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
[TBL] [Abstract][Full Text] [Related]
3. [Emotional and cognitive disorders in Parkinson disease].
Arsland D; Larsen JP
Tidsskr Nor Laegeforen; 1998 Oct; 118(25):3959-63. PubMed ID: 9830342
[TBL] [Abstract][Full Text] [Related]
4. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366
[TBL] [Abstract][Full Text] [Related]
5. Dopaminomimetic psychosis in Parkinson's disease patients: diagnosis and treatment.
Wolters EC
Neurology; 1999; 52(7 Suppl 3):S10-3. PubMed ID: 10227604
[TBL] [Abstract][Full Text] [Related]
6. Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.
Weintraub D; Hurtig HI
Am J Psychiatry; 2007 Oct; 164(10):1491-8. PubMed ID: 17898337
[TBL] [Abstract][Full Text] [Related]
7. [Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey].
Bailbé M; Karolewicz S; Neau JP; Dumas P; Gil R;
Rev Neurol (Paris); 2002 Feb; 158(2):203-10. PubMed ID: 11965176
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis between early Parkinson's disease and dementia with Lewy bodies.
Sulkava R
Adv Neurol; 2003; 91():411-3. PubMed ID: 12442700
[No Abstract] [Full Text] [Related]
9. Pimavanserin Treatment for Psychosis in Patients with Dementia with Lewy Bodies: A Case Series.
Rothenberg KG; McRae SG; Dominguez-Colman LM; Shutes-David A; Tsuang DW
Am J Case Rep; 2023 Sep; 24():e939806. PubMed ID: 37775968
[TBL] [Abstract][Full Text] [Related]
10. [Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient].
Ceballos-Baumann AO
MMW Fortschr Med; 2002 May; Suppl 2():37-43. PubMed ID: 12070848
[TBL] [Abstract][Full Text] [Related]
11. [Psychological and cognitive problems in Parkinson disease--therapeutic possibilities].
Baronti F
Praxis (Bern 1994); 2002 Mar; 91(10):411-7. PubMed ID: 11933648
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology and treatment of psychosis in Parkinson's disease: a review.
Zahodne LB; Fernandez HH
Drugs Aging; 2008; 25(8):665-82. PubMed ID: 18665659
[TBL] [Abstract][Full Text] [Related]
13. Clozapine for psychosis in Parkinson's disease.
Pfeiffer RF; Kang J; Graber B; Hofman R; Wilson J
Mov Disord; 1990; 5(3):239-42. PubMed ID: 2388641
[TBL] [Abstract][Full Text] [Related]
14. Avoiding mental changes and falls in older Parkinson's patients.
Paulson GW; Schafer K; Hallum B
Geriatrics; 1986 Aug; 41(8):59-62, 67. PubMed ID: 3732809
[TBL] [Abstract][Full Text] [Related]
15. Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease.
Zoldan J; Friedberg G; Weizman A; Melamed E
Adv Neurol; 1996; 69():541-4. PubMed ID: 8615178
[No Abstract] [Full Text] [Related]
16. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Scheepmaker AJ; Horstink MW; Hoefnagels WH; Strijks FE
Ned Tijdschr Geneeskd; 2003 Jan; 147(1):32-5. PubMed ID: 12564296
[TBL] [Abstract][Full Text] [Related]
17. [Dopaminomimetic psychosis in Parkinson's disease: first symptom of early dementia?].
Catalan-Alonso MJ; Del Val J
Rev Neurol; 2001 Jun 1-15; 32(11):1085-7. PubMed ID: 11562835
[TBL] [Abstract][Full Text] [Related]
18. Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease.
Morgante L; Epifanio A; Spina E; Di Rosa AE; Zappia M; Basile G; La Spina P; Quattrone A
Neurol Sci; 2002 Sep; 23 Suppl 2():S89-90. PubMed ID: 12548358
[TBL] [Abstract][Full Text] [Related]
19. [Drug treatment is beneficial also for elderly patients with Parkinson disease. Important to consider also other co-existing diseases].
Granérus AK
Lakartidningen; 2001 Mar; 98(13):1515-23. PubMed ID: 11330147
[TBL] [Abstract][Full Text] [Related]
20. Delusional misidentification in association with parkinsonism.
Roane DM; Rogers JD; Robinson JH; Feinberg TE
J Neuropsychiatry Clin Neurosci; 1998; 10(2):194-8. PubMed ID: 9608408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
